APE Antibody [F3K5]

Catalog No.: F7629

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:2000
    1:250
    1:500
    1:200
    Application
    WB, IHC, IF, FCM, ChIP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    35 kDa 35 kDa, 37 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    APE Antibody [F3K5] detects endogenous levels of total APE protein.
    Clone
    F3K5
    Synonym(s)
    APE, APE1, APEX, APX, HAP1, REF1, APEX1, APEX nuclease, Apurinic-apyrimidinic endonuclease 1, Redox factor-1, APEN, AP endonuclease 1, APE-1, REF-1
    Background
    Apurinic/apyrimidinic endonuclease 1 (APE1, also known as APEX1 or Ref‑1) is the major abasic site endonuclease in mammalian cells and a multifunctional nuclear protein that integrates base excision repair with redox regulation of transcription factors and broader DNA damage response signaling. The protein belongs to the divalent metal‑dependent α/β phosphoesterase superfamily and contains a structured C‑terminal catalytic core with active‑site residues and flexible loops that mediate DNA binding, lesion recognition, and incision chemistry, together with a unique N‑terminal segment that provides nuclear targeting and interaction interfaces for partner proteins and modulates localization and regulatory functions. APE1 recognizes abasic sites generated during base excision repair or by spontaneous base loss, flips the lesion into a compact active site pocket, and cleaves the phosphodiester backbone 5′ to the abasic nucleotide to create a nick with 3′‑hydroxyl and 5′‑deoxyribose phosphate termini that are suitable for subsequent gap filling by DNA polymerase β and ligation, thereby preventing accumulation of toxic AP sites and single‑strand breaks. The enzyme also removes a range of 3′‑blocking groups such as 3′‑phosphates and 3′‑phosphoglycolates through 3′‑repair diesterase and 3′‑exonuclease activities, directly contributing to processing of DNA ends arising from oxidative and radiation‑induced damage and facilitating completion of multiple repair pathways. Additional nucleotide incision repair activity enables APE1 to incise some oxidatively damaged bases directly without prior glycosylase action, expanding its role beyond canonical BER and connecting it to alternative repair routes for oxidized purines and pyrimidines. A redox‑regulatory function resides in the N‑terminal region, where APE1 maintains critical cysteine residues of transcription factors such as AP‑1, NF‑κB, HIF‑1α, and others in a reduced state that favors DNA binding, thereby coupling cellular redox status and DNA damage to transcriptional responses that govern inflammation, angiogenesis, and stress adaptation. APE1 interacts with numerous DNA repair and chromatin‑associated partners, forming a central hub in the BER interactome that coordinates lesion recognition, repair synthesis, and chromatin access and that also interfaces with ATM/ATR‑mediated checkpoint pathways, positioning APE1 as a regulator of genome stability and cell fate after genotoxic stress. Tight regulation of APE1 expression, subcellular distribution, and post‑translational modification is essential for cell viability; depletion is lethal in mouse embryos and compromises resistance to oxidative and alkylation damage, while abnormal overexpression, mislocalization, or altered activity are reported in a range of cancers and neuropathologies and associate with therapy resistance and disease susceptibility.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください